Guardant Health, Inc. (GH): Price and Financial Metrics

Guardant Health, Inc. (GH): $23.60

0.60 (+2.61%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

GH Price/Volume Stats

Current price $23.60 52-week high $37.04
Prev. close $23.00 52-week low $15.81
Day low $22.92 Volume 1,967,000
Day high $24.32 Avg. volume 2,036,936
50-day MA $23.11 Dividend yield N/A
200-day MA $23.99 Market Cap 2.90B

GH Stock Price Chart Interactive Chart >


Guardant Health, Inc. (GH) Company Bio


Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.


GH Latest News Stream


Event/Time News Detail
Loading, please wait...

GH Latest Social Stream


Loading social stream, please wait...

View Full GH Social Stream

GH Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!